Bekéné Debreceni Ildikó

Name: Bekéné Debreceni Ildikó

Degree:

PhD, Laki Kálmán Doktori Iskola (2021)

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2008-2024

2024

Nagy, Z., Árvai, K., Lakatos, P., Bekéné Debreceni, I., Szili, B., Istenes, I., Bödör, C., Demeter, J.: Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia.
Pathol. Oncol. Res. 30, 1-8, (article identifier: 1611914), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

Kappelmayer, J., Bekéné Debreceni, I., Fejes, Z., Nagy, B. J.: Inflammation, Sepsis, and the Coagulation System.
Hamostaseologie. 44 (4), 268-276, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

Ghansah, H., Orbán-Kálmándi, R. A., Bekéné Debreceni, I., Katona, É., Rejtő, L., Váróczy, L., Lóczi, L., Laat, B. d., Huskens, D., Kappelmayer, J., Bagoly, Z.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234, 12-20, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

Gonda, L., Torner, B., Ghansah, H., Bekéné Debreceni, I., Váróczy, L., Pénzes-Daku, K., Kappelmayer, J.: Monoclonal whole IgG impairs both fibrin and thrombin formation: hemostasis and surface plasmon resonance studies.
Clin. Chem. Lab. Med. 62 (9), 1863-1869, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

Krajcsir, B., Pócsi, M., Fejes, Z., Nagy, B. J., Kappelmayer, J., Bekéné Debreceni, I.: Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis.
Pharmaceutics. 16 (4), 1-14, (article identifier: 559), 2024.

doi DEA Scopus

Journal metrics:

D1 Pharmaceutical Science

2023

Ghansah, H., Bekéné Debreceni, I., Váróczy, L., Rejtő, L., Lóczi, L., Bagoly, Z., Kappelmayer, J.: Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
Thromb. Res. 223, 44-52, 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Hematology

Illési, Á., Fejes, Z., Pócsi, M., Bekéné Debreceni, I., Hódosi, K., Nagy, B. J., Kappelmayer, J., Kőszegi, Z., Csanádi, Z., Szűk, T.: Technically Challenging Percutaneous Interventions of Chronic Total Occlusions Are Associated with Enhanced Platelet Activation.
J Clin Med. 12 (21), 1-14, (article identifier: 6829), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

2022

Somodi, L., Bekéné Debreceni, I., Kis, G., Cozzolino, M., Kappelmayer, J., Antal, M., Panyi, G., Bárdos, H., Mutch, N. J., Muszbek, L.: Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
J. Thromb. Haemost. 20 (5), 1223-1235, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

D1 Medicine (miscellaneous)

Illési, Á., Bekéné Debreceni, I., Fejes, Z., Nagy, B. J., Hódosi, K., Kappelmayer, J., Csanádi, Z., Szűk, T.: Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion.
Thromb. Res. 217, 64-72, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Hematology

2021

10.

Szabó, G., Bekéné Debreceni, I., Tarr, T., Soltész, P., Osterud, B., Kappelmayer, J.: Anti-[beta]2-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms.
Thromb. Res. 197, 124-131, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Hematology

11.

Mezei, G., Batár, P., Kozma, L., Illés, Á., Kappelmayer, J., Bekéné Debreceni, I.: Ponatinib Exerts an Inhibitory Effect on Collagen-induced Platelet Aggregation and Generation of Coated-Platelets.
Anticancer Res. 41 (10), 4867-4874, 2021.

doi DEA

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

12.

Ghansah, H., Bekéné Debreceni, I., Fejes, Z., Nagy, B. J., Kappelmayer, J.: The Proteasome Inhibitor Bortezomib Induces Apoptosis and Activation in Gel-Filtered Human Platelets.
Int. J. Mol. Sci. 22 (16), 1-13, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2019

13.

Orosz, Z. Z., Bárdos, H., Shemirani, A. H., Bekéné Debreceni, I., Lassila, R., Riikonen, A. S., Kremer Hovinga, J. A., Seiler, T. G., van Dorland, H. A., Schroeder, V., Boda, Z., Nemes, L., Früh Eppstein, B., Nagy, B., Facskó, A., Kappelmayer, J., Muszbek, L.: Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Int. J. Mol. Sci. 20 (23), 1-17, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

14.

Mezei, G., Bekéné Debreceni, I., Kerényi, A., Reményi, G., Szász, R., Illés, Á., Kappelmayer, J., Batár, P.: Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia.
Platelets. 30 (7), 836-843, 2019.

doi DEA

Journal metrics:

Q2 Hematology

Q1 Medicine (miscellaneous)

15.

Bekéné Debreceni, I., Mezei, G., Batár, P., Illés, Á., Kappelmayer, J.: Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets.
Int. J. Mol. Sci. 20 (21), 1-14, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

16.

Gyöngyösi, A., Szőke, K., Fenyvesi, F., Fejes, Z., Bekéné Debreceni, I., Nagy, B. J., Tósaki, Á., Lekli, I.: Inhibited autophagy may contribute to heme toxicity in cardiomyoblast cells.
Biochem. Biophys. Res. Commun. 511 (4), 732-738, 2019.

doi DEA

Journal metrics:

Q2 Biochemistry

Q1 Biophysics

Q3 Cell Biology

Q3 Molecular Biology

17.

Bekéné Debreceni, I., Szász, R., Kónya, Z., Erdődi, F., Kiss, F., Kappelmayer, J.: L-Selectin Expression Is Influenced by Phosphatase Activity in Chronic Lymphocytic Leukemia.
Cytom. Part B-Clin. Cytom. 96 (2), 149-157, 2019.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Histology

Q1 Pathology and Forensic Medicine

2017

18.

Tóth, J., Bekéné Debreceni, I., Deák, Á., Pető, K., Berhés, M., Hajdu, E., Szabó, J., Németh, N., Fülesdi, B., Kappelmayer, J.: Characteristics of thrombin generation in a fulminant in a fulminant porcine sepsis model.
Thromb. Res. 158, 25-34, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

19.

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B. J., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Histology

Q1 Pathology and Forensic Medicine

20.

Fejes, Z., Póliska, S., Czimmerer, Z., Káplár, M., Penyige, A., Gál Szabó, G., Bekéné Debreceni, I., Kunapuli, S. P., Kappelmayer, J., Nagy, B. J.: Hyperglycemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
Thromb. Haemost. 117 (3), 529-542, 2017.

doi DEA

Journal metrics:

Q1 Hematology

21.

Hudák, R., Bekéné Debreceni, I., Deák, I., Gál Szabó, G., Hevessy, Z., Antal-Szalmás, P., Osterud, B., Kappelmayer, J.: Laboratory characterization of leukemic cell procoagulants.
Clin. Chem. Lab. Med. 55 (8), 1215-1223, 2017.

DEA

Journal metrics:

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

22.

Tóth, J., Bekéné Debreceni, I., Berhés, M., Hajdu, E., Deák, Á., Pető, K., Szabó, J., Németh, N., Fülesdi, B., Kappelmayer, J.: Red blood cell and platelet parameters are sepsis predictors in an Escherichia coli induced lethal porcine modell.
Clin. Hemorheol. Microcirc. 66 (3), 249-259, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

Q3 Hematology

Q3 Physiology

Q3 Physiology (medical)

23.

Hudák, R., Vincze, J., Csernoch, L., Bekéné Debreceni, I., Oláh, T., Erdődi, F., Clemetson, K. J., Kappelmayer, J.: The phosphatase inhibitor calyculin-A impairs clot retraction, platelet activation and thrombin generation.
Biomed Res. Int. 2017, 1-10, 2017.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Immunology and Microbiology (miscellaneous)

Q1 Medicine (miscellaneous)

2016

24.

Becs, G., Hudák, R., Fejes, Z., Bekéné Debreceni, I., Bhattoa, H. P., Balla, J., Kappelmayer, J.: Haemodiafiltration elicits less platelet activation compared to haemodialysis.
BMC Nephrol. 17 (1), 147, 2016.

doi DEA

Journal metrics:

Q1 Nephrology

25.

Szűk, T., Fejes, Z., Bekéné Debreceni, I., Kerényi, A., Édes, I. F., Kappelmayer, J., Nagy, B. J.: Integrity bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience everolimus-eluting stents in stable angina patients.
Platelets. 27 (5), 410-419, 2016.

doi DEA

Journal metrics:

Q2 Hematology

Q2 Medicine (miscellaneous)